Market Opportunity

Facilitating the Migration to Outpatient & Ambulatory Settings

VUZE is aiming to provide an improved standard of care for guiding spinal interventions that are performed manually on short segments and currently assisted only by 2D X-Ray. Such procedures account for the majority of the market, yet their guidance has seen very little innovation for decades.

Demand for VUZE is foreseen to accelerate in the aftermath of COVID-19, due to: [i] mounting pressures to reduce capital expenditures and contain operating costs; and [ii] greater avoidance of hospitalization by opting for minimally-invasive surgery in outpatient/ambulatory settings where reliance upon X-Ray guidance is particularly high.

Immediate focus is on spinal stabilization by implants or cement injections, with three million applicable surgeries annually. Other spinal (e.g., endoscopies, injections) and skeletal interventions are expected to follow.

VUZE is not aiming to compete directly with hardware-based navigation and robotic systems. Those elaborate and expensive setups are used primarily in complex surgeries performed at large medical centers and thus address only a limited (and yet intensely competitive) market segment.

Matriza no arrow dark@4x.png



* Configurable by software with VUZE